naltrexone has been researched along with AIDS-Related Opportunistic Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bihari, B | 1 |
2 other study(ies) available for naltrexone and AIDS-Related Opportunistic Infections
Article | Year |
---|---|
Efficacy of low dose naltrexone as an immune stabilizing agent for the treatment of HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Humans; Naltrexone | 1995 |
Interviews and anecdotal reports.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Breast Neoplasms; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Complementary Therapies; Diet; Drug Therapy, Combination; HIV Infections; Humans; Hypersensitivity, Delayed; Naltrexone; Viral Load | 1998 |